These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Effects of prostaglandins and nitric oxide on the renal effects of angiotensin II in the anaesthetized rat. Clayton JS; Clark KL; Johns EJ; Drew GM Br J Pharmacol; 1998 Aug; 124(7):1467-74. PubMed ID: 9723960 [TBL] [Abstract][Full Text] [Related]
7. Regulation of glomerular filtration in essential hypertension: role of abnormal Na+ transport and atrial natriuretic peptide. Semplicini A; Ceolotto G; Sartori M; Maresca A; Baritono E; De Toni R; Paparella I; Calò L J Nephrol; 2002; 15(5):489-96. PubMed ID: 12455714 [TBL] [Abstract][Full Text] [Related]
10. The role of nitric oxide in the regulation of glomerular haemodynamics in humans. Delles C; Klingbeil AU; Schneider MP; Handrock R; Schäufele T; Schmieder RE Nephrol Dial Transplant; 2004 Jun; 19(6):1392-7. PubMed ID: 15004251 [TBL] [Abstract][Full Text] [Related]
11. Alterations of renal hemodynamics in unilateral ureteral obstruction mediated by activation of endothelin receptor subtypes. Bhangdia DK; Gulmi FA; Chou SY; Mooppan UM; Kim H J Urol; 2003 Nov; 170(5):2057-62. PubMed ID: 14532853 [TBL] [Abstract][Full Text] [Related]
12. Expression and response to angiotensin-converting enzyme inhibition of matrix metalloproteinases 2 and 9 in renal glomerular damage in young transgenic rats with renin-dependent hypertension. Bolbrinker J; Markovic S; Wehland M; Melenhorst WB; van Goor H; Kreutz R J Pharmacol Exp Ther; 2006 Jan; 316(1):8-16. PubMed ID: 16166267 [TBL] [Abstract][Full Text] [Related]
14. Renoprotective effects of an angiotensin II receptor blocker in experimental model rats with hypertension and metabolic disorders. Watanabe D; Tanabe A; Naruse M; Morikawa S; Ezaki T; Takano K Hypertens Res; 2009 Sep; 32(9):807-15. PubMed ID: 19662019 [TBL] [Abstract][Full Text] [Related]
15. Hemodynamic-independent anti-natriuretic effect of urotensin II in spontaneously hypertensive rats. Shi Y; Cao YX; Lu N; Yao T; Zhu YC Peptides; 2008 May; 29(5):783-94. PubMed ID: 18420307 [TBL] [Abstract][Full Text] [Related]
16. Role of the renin-angiotensin-aldosterone system in the progression of renal disease: a critical review. Ibrahim HN; Rosenberg ME; Hostetter TH Semin Nephrol; 1997 Sep; 17(5):431-40. PubMed ID: 9316211 [TBL] [Abstract][Full Text] [Related]
17. Sexual dimorphism of the aging kidney: role of nitric oxide deficiency. Baylis C Physiology (Bethesda); 2008 Jun; 23():142-50. PubMed ID: 18556467 [TBL] [Abstract][Full Text] [Related]
18. Effect of light exercise on renal hemodynamics in patients with hypertension and chronic renal disease. Svarstad E; Myking O; Ofstad J; Iversen BM Scand J Urol Nephrol; 2002; 36(6):464-72. PubMed ID: 12623513 [TBL] [Abstract][Full Text] [Related]
19. Aging and the kidney: adjusting treatment to physiologic change. Lonergan ET Geriatrics; 1988 Mar; 43(3):27-30, 32-3. PubMed ID: 3277889 [TBL] [Abstract][Full Text] [Related]
20. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease]. Alcázar Arroyo R Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]